Victory Capital Management Inc. Grows Position in Colgate-Palmolive (NYSE:CL)

Victory Capital Management Inc. raised its holdings in shares of Colgate-Palmolive (NYSE:CL) by 5.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,830,787 shares of the company’s stock after purchasing an additional 88,674 shares during the quarter. Victory Capital Management Inc. owned approximately 0.22% of Colgate-Palmolive worth $145,932,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in CL. OFI Invest Asset Management purchased a new stake in Colgate-Palmolive during the third quarter valued at about $25,000. Avion Wealth lifted its holdings in shares of Colgate-Palmolive by 78.1% in the fourth quarter. Avion Wealth now owns 399 shares of the company’s stock worth $32,000 after buying an additional 175 shares in the last quarter. McGlone Suttner Wealth Management Inc. purchased a new stake in shares of Colgate-Palmolive in the fourth quarter worth about $34,000. Kayne Anderson Rudnick Investment Management LLC lifted its holdings in shares of Colgate-Palmolive by 142.0% in the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock worth $35,000 after buying an additional 291 shares in the last quarter. Finally, West Branch Capital LLC lifted its holdings in shares of Colgate-Palmolive by 24.0% in the fourth quarter. West Branch Capital LLC now owns 682 shares of the company’s stock worth $54,000 after buying an additional 132 shares in the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Down 0.0 %

Shares of NYSE CL opened at $91.90 on Thursday. Colgate-Palmolive has a one year low of $67.62 and a one year high of $92.54. The company has a debt-to-equity ratio of 13.21, a current ratio of 1.06 and a quick ratio of 0.28. The firm’s 50 day simple moving average is $88.08 and its two-hundred day simple moving average is $81.99. The stock has a market capitalization of $75.40 billion, a P/E ratio of 29.08, a PEG ratio of 3.39 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, April 26th. The company reported $0.86 EPS for the quarter, beating analysts’ consensus estimates of $0.82 by $0.04. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The business had revenue of $5.07 billion for the quarter, compared to analysts’ expectations of $4.96 billion. During the same period last year, the business earned $0.73 earnings per share. The business’s quarterly revenue was up 6.2% on a year-over-year basis. As a group, analysts expect that Colgate-Palmolive will post 3.52 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be given a dividend of $0.50 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. This represents a $2.00 dividend on an annualized basis and a yield of 2.18%. The ex-dividend date of this dividend is Friday, April 19th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 63.29%.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 50,000 shares of the stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the transaction, the chief executive officer now directly owns 274,179 shares in the company, valued at $22,797,983.85. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, CEO Noel R. Wallace sold 50,000 shares of the firm’s stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $83.15, for a total value of $4,157,500.00. Following the transaction, the chief executive officer now owns 274,179 shares in the company, valued at $22,797,983.85. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jennifer Daniels sold 3,538 shares of the firm’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $84.67, for a total transaction of $299,562.46. Following the completion of the transaction, the insider now owns 59,698 shares in the company, valued at approximately $5,054,629.66. The disclosure for this sale can be found here. Insiders have sold 159,048 shares of company stock worth $13,336,846 over the last ninety days. Insiders own 0.34% of the company’s stock.

Wall Street Analysts Forecast Growth

CL has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. increased their price target on shares of Colgate-Palmolive from $88.00 to $90.00 and gave the stock an “overweight” rating in a report on Thursday, January 18th. StockNews.com downgraded shares of Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a report on Tuesday, February 20th. Evercore ISI increased their price target on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the stock an “outperform” rating in a report on Monday, April 8th. TheStreet raised shares of Colgate-Palmolive from a “c+” rating to a “b+” rating in a report on Friday, January 26th. Finally, The Goldman Sachs Group assumed coverage on shares of Colgate-Palmolive in a report on Friday, March 1st. They issued a “buy” rating and a $93.00 price target on the stock. Three research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $91.44.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.